Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02274246Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Proportion of subjects with contrast enhancement in left atrium. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02274246.